Abstract 2819: Efficacy and safety of the Ad-GM·CAIX dendritic cell-based vaccine in treatingin vivometastatic renal cell carcinoma compared to sunitinib monotherapy and simultaneous vaccine-sunitinib combination therapy

Published

Conference Paper

Full Text

Cited Authors

  • Rampersaud, EN; Said, JW; Bot, A; Birkhäuser, FD; Kroeger, N; Zeng, G; Kabbinavar, FF; Ribas, A; Pantuck, AJ; Belldegrun, AS; Riss, J

Published Date

  • October 1, 2014

Published In

  • Immunology

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.am2014-2819

Conference Name

  • Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA